Long-Term, Patient-Level Analysis of Radiofrequency Renal Denervation in the SYMPLICITY Clinical Trial Program
Modeling suggested patients have durable BP reductions following RDN, with a steep immediate reduction followed by a steady reduction through 3 years.
Authors
- Lucas Lauder (ORCID: https://orcid.org/0000-0003-1434-9556)
- Michael Böhm (ORCID: https://orcid.org/0000-0002-2976-2514)
- Deepak L. Bhatt (ORCID: https://orcid.org/0000-0002-1278-6245)
- Felix Mahfoud (ORCID: https://orcid.org/0000-0002-4425-549X)
- Raymond R. Townsend (ORCID: https://orcid.org/0000-0002-3215-9118)
- Markus Peter Schlaich (ORCID: https://orcid.org/0000-0002-1765-0195)
- Kazuomi Kario
- Martin Fahy
- David E. Kandzari (ORCID: https://orcid.org/0000-0002-0868-6655)
- Giuseppe Mancia (ORCID: https://orcid.org/0000-0003-0942-3176)
- Robert Whitbourn
- Roland E. Schmieder (ORCID: https://orcid.org/0000-0003-2356-5883)
Institutions
- Jichi Medical University (JP)
- Royal Perth Hospital (AU)
- Piedmont Atlanta Hospital (US)
- University Hospital of Basel (CH)
- Universitätsklinikum Erlangen (DE)
- Medtronic (United States) (US)
- Hospital Base (CL)
- Universitätsklinikum des Saarlandes (DE)
- St Vincent's Health (AU)
- Mount Sinai Hospital (US)
- Australian Centre for Heart Health (AU)
- University of Milano-Bicocca (IT)
- University of Pennsylvania (US)
- Icahn School of Medicine at Mount Sinai (US)
Publication Details
- Journal
- JACC Advances
- Published
- 2025-02-21
- DOI
- https://doi.org/10.1016/j.jacadv.2025.101606
- Citations
- 14
- Primary Topic
- Blood Pressure and Hypertension Studies
- Type
- article
- Field-Weighted Citation Impact
- 19.43
Funders
- Universitätsspital Basel